Journal of Cancer
Overview
The Journal of Cancer is a peer-reviewed publication dedicated to advancing the understanding and treatment of cancer. It features cutting-edge research articles, reviews, and clinical studies that cover various aspects of cancer biology, diagnosis, prevention, and therapy. With a multidisciplinary approach, the journal serves as a valuable resource for researchers, clinicians, and healthcare professionals striving to improve cancer outcomes and patient care.
Details
Details
Metrics
Metrics
h-index / Ranks: 4277
81
SJR / Ranks: 4476
901
CiteScore / Ranks: 2299
7.90
JIF / Ranks: 2352
3.9
Recent Articles
21.
Chen P, Lu Y, Yang W, Su C, Chang L, Yang S, et al.
J Cancer
. 2025 Feb;
16(5):1747-1753.
PMID: 39991569
Epigenetic, genetic predisposition and epidemiological risk factors were suggested to be involved in the carcinogenesis of oral cancer. In this study, we focused on the associations of MET single-nucleotide polymorphisms...
22.
Jiang Y, Jiang D, Chen J, Feng H, Zhu Z, Jiang J, et al.
J Cancer
. 2025 Feb;
16(5):1451-1465.
PMID: 39991568
Currently, there is no established standard for managing resectable synchronous colorectal liver metastases (CRLM): upfront surgery or neoadjuvant therapy. This study has integrated four available clinical factors - clinicopathological characteristics,...
23.
Zhang W, Yang L, Li M, Zhang L, Cheng J, El-Far A, et al.
J Cancer
. 2025 Feb;
16(5):1736-1746.
PMID: 39991567
A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) plays critical roles in various cancer-associated biological events, such as cell multiplication, migration, and metastasis. This study employs both the TCGA database...
24.
Ho I, Tseng Y, Liu C, Tsai Y, Huang C, Tseng L, et al.
J Cancer
. 2025 Feb;
16(5):1726-1735.
PMID: 39991566
Despite rapidly improving therapeutics, challenges remain in the treatment of advanced breast cancer. Vinorelbine, a semisynthetic vinca alkaloid, is effective and well-tolerated in breast cancer treatment. The combination of vinorelbine...
25.
Fang W, Zhang X, Yu Y, Ge J, Meng R
J Cancer
. 2025 Feb;
16(5):1555-1562.
PMID: 39991565
Propofol is a common intravenous anesthetic in cancer resection surgery, which is considered to exhibit anti-tumor effect in various cancer types. This study was aimed at investigating the role and...
26.
Zhao K, Lin J, Li Y, Xu S, Wang F, Yang Y
J Cancer
. 2025 Feb;
16(4):1149-1166.
PMID: 39895803
Background: KANK2, a gene crucial for cell migration and movement, is implicated in neoplastic and non-neoplastic diseases. This study aimed to analyze KANK2's expression and its diagnostic and prognostic significance...
27.
Zhong C, Wang W, Yao Y, Lian S, Xie X, Xu J, et al.
J Cancer
. 2025 Feb;
16(4):1310-1323.
PMID: 39895802
Metastasis is the leading cause of cancer-related deaths and poses a treatment challenge. Although studies have shown the importance of epithelial-mesenchymal transition (EMT) and metabolic reprogramming during cancer metastasis, the...
28.
Ma K, Zhang C
J Cancer
. 2025 Feb;
16(4):1347.
PMID: 39895801
[This retracts the article DOI: 10.7150/jca.62787.].
29.
Li M, Chen W, Shia B, Wu S
J Cancer
. 2025 Feb;
16(4):1054-1065.
PMID: 39895800
Herpes zoster is a significant complication in cancer patients, particularly those with compromised immune systems. Previous studies have established the incidence of herpes zoster in gastrointestinal cancer patients, but there...
30.
Zhou X, Wu J, Liu Y, Wang X, Gao X, Xia X, et al.
J Cancer
. 2025 Feb;
16(4):1243-1263.
PMID: 39895799
This study aimed to investigate glycogen metabolism in gastric cancer (GC) and develop a glycogen-based riskScore model for predicting GC prognosis. Patients' expression profiles for 33 tumor types were retrieved...